TNDM:NASDAQ
Tandem Diabetes Care Inc
$16.87
arrow_downward
-2.09%(-0.36) 1D
$16.78
arrow_downward
-0.53% (-0.090)bedtimeAfter hours
Closed: Sep 18, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TNDM...
Open
$17.13
High
$17.15
Low
$16.77
Mkt. cap
1.17B
Avg. vol.
1.88M
Volume
2.28M
52-wk high
$29.65
52-wk low
$11.46
EPS
-$0.93
Beta
1.55
Shares outstanding
69.58M
No. of employees
2K
Open
$17.13
High
$17.15
Low
$16.77
Mkt. cap
1.17B
Avg. vol.
1.88M
Volume
2.28M
52-wk high
$29.65
52-wk low
$11.46
EPS
-$0.93
Beta
1.55
Shares outstanding
69.58M
No. of employees
2K
News stories
From web sources and news partners
Yahoo Finance
·
1 day ago
Tandem Diabetes Care (TNDM) Soars 7.7%: Is Further Upside Left in the Stock?
CarePlus VietNam
·
3 weeks ago
Tandem (TNDM) Results Versus Estimates: Reported EPS Tops Expectations on the Day; Session Move: Shares Finish 2.88% Down in the Current Update - Earnings Quality Analysis
CarePlus VietNam
·
2 months ago
Tandem Diabetes Care (TNDM) Surges 5.45% as Bulls Defend Key Support - Rip Sell Trade
Profile
Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software. Headquartered in San Diego, California, its principal pump platforms are the t:slim X2 and Tandem Mobi, both of which use the company's Control-IQ+ software with compatible continuous glucose monitors.
Tandem was founded in 2006 and introduced its first pump, the touchscreen t:slim, in 2012. The company became publicly traded on the Nasdaq in 2013. By the end of 2025 it reported an in-warranty user base of nearly 500,000 people in more than 25 countries and annual sales of $1.015 billion. Wikipedia
About Tandem Diabetes Care Inc
CEOJohn Sheridan
Employees2.5K
FoundedJan 2006
Headquarters-
SectorMedical device
Websitetandemdiabetes.com